Osaic Holdings
KRTX

Osaic Holdings’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Osaic Holdings’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,618
Closed -$512K – 7478
2023
Q4 		$512K Buy
1,618
+236
+17% +$45.9K ﹤0.01% 3153
2023
Q3 		$234K Buy
1,382
+324
+31% +$60.9K ﹤0.01% 3884
2023
Q2 		$229K Buy
1,058
+435
+70% +$93.2K ﹤0.01% 3783
2023
Q1 		$113K Buy
623
+188
+43% +$36K ﹤0.01% 4341
2022
Q4 		$86.2K Buy
435
+140
+47% +$30K ﹤0.01% 4558
2022
Q3 		$66K Buy
295
+186
+171% +$37.6K ﹤0.01% 4694
2022
Q2 		$14K Buy
109
+13
+14% +$1.49K ﹤0.01% 5877
2022
Q1 		$12K Sell
96
-331
-78% -$37.3K ﹤0.01% 6043
2021
Q4 		$56K Buy
427
+335
+364% +$43.3K ﹤0.01% 5063
2021
Q3 		$11K Sell
92
-2
-2% -$231 ﹤0.01% 6161
2021
Q2 		$11K Buy
94
+5
+6% +$584 ﹤0.01% 6029
2021
Q1 		$11K Buy
89
+23
+35% +$2.61K ﹤0.01% 5840
2020
Q4 		$7K Hold
66
– – ﹤0.01% 5675
2020
Q3 		$5K Sell
66
-138
-68% -$11.8K ﹤0.01% 5594
2020
Q2 		$23K Buy
204
+119
+140% +$10.3K ﹤0.01% 4729
2020
Q1 		$7K Buy
+85
New +$7.27K ﹤0.01% 5218

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Osaic Holdings's KRTX Position: Q1 2024 in Review

Osaic Holdings sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,618 shares — an estimated $512K sold.

Osaic Holdings first reported a position in KRTX in Q1 2020 and held it in 16 quarters. The position peaked at $512K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Osaic Holdings reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Osaic Holdings sold 1,618 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $512K.
  • Osaic Holdings first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 16 quarters.
  • Osaic Holdings's Karuna Therapeutics, Inc. Common Stock position peaked at $512K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Osaic Holdings's 13F filing for Q1 2024, filed 10 May 2024.